Cargando…

Pathogenesis of Liver Fibrosis and Its TCM Therapeutic Perspectives

Liver fibrosis is a pathological process of abnormal tissue proliferation in the liver caused by various pathogenic factors, which will further develop into cirrhosis or even hepatocellular carcinoma if liver injury is not intervened in time. As a diffuse progressive liver disease, its clinical mani...

Descripción completa

Detalles Bibliográficos
Autores principales: Nan, Yang, Su, HongChan, Lian, XiaoMei, Wu, Juan, Liu, SuJie, Chen, PingPing, Liu, ShuMin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071861/
https://www.ncbi.nlm.nih.gov/pubmed/35529927
http://dx.doi.org/10.1155/2022/5325431
_version_ 1784700922580959232
author Nan, Yang
Su, HongChan
Lian, XiaoMei
Wu, Juan
Liu, SuJie
Chen, PingPing
Liu, ShuMin
author_facet Nan, Yang
Su, HongChan
Lian, XiaoMei
Wu, Juan
Liu, SuJie
Chen, PingPing
Liu, ShuMin
author_sort Nan, Yang
collection PubMed
description Liver fibrosis is a pathological process of abnormal tissue proliferation in the liver caused by various pathogenic factors, which will further develop into cirrhosis or even hepatocellular carcinoma if liver injury is not intervened in time. As a diffuse progressive liver disease, its clinical manifestations are mostly excessive deposition of collagen-rich extracellular matrix resulting in scar formation due to liver injury. Hepatic fibrosis can be caused by hepatitis B and C, fatty liver, alcohol, and rare diseases such as hemochromatosis. As the metabolic center of the body, the liver regulates various vital activities. During the development of fibrosis, it is influenced by many other factors in addition to the central event of hepatic stellate cell activation. Currently, with the increasing understanding of TCM, the advantages of TCM with multiple components, pathways, and targets have been demonstrated. In this review, we will describe the factors influencing liver fibrosis, focusing on the effects of cells, intestinal flora, iron death, signaling pathways, autophagy and angiogenesis on liver fibrosis, and the therapeutic effects of herbal medicine on liver fibrosis.
format Online
Article
Text
id pubmed-9071861
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-90718612022-05-06 Pathogenesis of Liver Fibrosis and Its TCM Therapeutic Perspectives Nan, Yang Su, HongChan Lian, XiaoMei Wu, Juan Liu, SuJie Chen, PingPing Liu, ShuMin Evid Based Complement Alternat Med Review Article Liver fibrosis is a pathological process of abnormal tissue proliferation in the liver caused by various pathogenic factors, which will further develop into cirrhosis or even hepatocellular carcinoma if liver injury is not intervened in time. As a diffuse progressive liver disease, its clinical manifestations are mostly excessive deposition of collagen-rich extracellular matrix resulting in scar formation due to liver injury. Hepatic fibrosis can be caused by hepatitis B and C, fatty liver, alcohol, and rare diseases such as hemochromatosis. As the metabolic center of the body, the liver regulates various vital activities. During the development of fibrosis, it is influenced by many other factors in addition to the central event of hepatic stellate cell activation. Currently, with the increasing understanding of TCM, the advantages of TCM with multiple components, pathways, and targets have been demonstrated. In this review, we will describe the factors influencing liver fibrosis, focusing on the effects of cells, intestinal flora, iron death, signaling pathways, autophagy and angiogenesis on liver fibrosis, and the therapeutic effects of herbal medicine on liver fibrosis. Hindawi 2022-04-28 /pmc/articles/PMC9071861/ /pubmed/35529927 http://dx.doi.org/10.1155/2022/5325431 Text en Copyright © 2022 Yang Nan et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Nan, Yang
Su, HongChan
Lian, XiaoMei
Wu, Juan
Liu, SuJie
Chen, PingPing
Liu, ShuMin
Pathogenesis of Liver Fibrosis and Its TCM Therapeutic Perspectives
title Pathogenesis of Liver Fibrosis and Its TCM Therapeutic Perspectives
title_full Pathogenesis of Liver Fibrosis and Its TCM Therapeutic Perspectives
title_fullStr Pathogenesis of Liver Fibrosis and Its TCM Therapeutic Perspectives
title_full_unstemmed Pathogenesis of Liver Fibrosis and Its TCM Therapeutic Perspectives
title_short Pathogenesis of Liver Fibrosis and Its TCM Therapeutic Perspectives
title_sort pathogenesis of liver fibrosis and its tcm therapeutic perspectives
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071861/
https://www.ncbi.nlm.nih.gov/pubmed/35529927
http://dx.doi.org/10.1155/2022/5325431
work_keys_str_mv AT nanyang pathogenesisofliverfibrosisanditstcmtherapeuticperspectives
AT suhongchan pathogenesisofliverfibrosisanditstcmtherapeuticperspectives
AT lianxiaomei pathogenesisofliverfibrosisanditstcmtherapeuticperspectives
AT wujuan pathogenesisofliverfibrosisanditstcmtherapeuticperspectives
AT liusujie pathogenesisofliverfibrosisanditstcmtherapeuticperspectives
AT chenpingping pathogenesisofliverfibrosisanditstcmtherapeuticperspectives
AT liushumin pathogenesisofliverfibrosisanditstcmtherapeuticperspectives